Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

Springer Science and Business Media LLC - Tập 11 - Trang 1313-1313 - 2022
Iris De Ryck1, Eleanna Sarakinou2, Usman Nakakana2, Giulia Luna Cilio1, Augustin Ndiaye3, Venanzio Vella1, Joachim Auerbach2,4, Juan-Paolo Granada5, Valentino Conti2, Audino Podda2
1GSK, Siena, Italy
2GSK Vaccines Institute for Global Health, Siena, Italy
3Takeda Pharmaceutical International AG, Zurich, Switzerland
4Coalition for Epidemic Preparedness Innovations, London, UK
5Ferring Pharmaceuticals, Copenhagen, Denmark

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 11

1313-1313

Thông tin tác giả